Retraction Note: Stem Cell Research & Therapy (2021) 12:349 https://doi.org/10.1186/s13287-021-02393-8
The Editors-in-Chief have retracted this article at the request of the Corresponding Author.
After publication, the authors identified flaws in the study design and the data.
Further assessment of the article identified the following issues:
-
The number of tumor cells inoculated into mice for the xenograft experiment was higher than recommended by internationally accepted standards.
-
In Fig. 2d, the western blot image backgrounds and empty spaces in lane 1 appear remarkably similar.
-
In Fig. 6c and d, a number of tumor images appear remarkably similar.
In addition, the authors were unable to locate the original ethics approval documents.
The Editors-in-Chief therefore no longer have confidence in the presented data and the conclusions of this article.
All authors agree to this retraction.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Zhang, R., Li, P., Lv, H. et al. Retraction Note to: Exosomal SNHG16 secreted by CSCs promotes glioma development via TLR7. Stem Cell Res Ther 13, 166 (2022). https://doi.org/10.1186/s13287-022-02842-y
Published:
DOI: https://doi.org/10.1186/s13287-022-02842-y